고강도 집속 초음파 시장 분석 및 예측(-2035년) : 유형, 기술, 구성 요소, 용도, 기기, 최종사용자

The global High Intensity Focused Ultrasound Market is projected to grow from $1.3 billion in 2025 to $2.6 billion by 2035, at a compound annual growth rate (CAGR) of 7.1%. The high intensity focused ultrasound market is witnessing strong commercial traction driven by increasing clinical adoption of non-invasive therapies and rising procedural volumes globally. According to company disclosures, EDAP TMS S.A. reported full-year 2025 HIFU revenue of around $37.4 million, reflecting a 39% year-over-year increase, highlighting strong demand for focused ultrasound systems in oncology and urology applications. The company also reported total revenue of around $70.5 million for 2025, reinforcing steady business expansion despite broader non-core segment declines. These figures underscore accelerating adoption of HIFU technologies across healthcare systems, driven by preference for minimally invasive, image-guided therapeutic solutions.

In the high intensity focused ultrasound market, the type segment includes ultrasound-based HIFU and MRI-based HIFU. Ultrasound-based HIFU dominates the market, accounting for approximately $833.7 Million in 2025, driven by its cost-effectiveness, real-time imaging guidance, and wider availability in outpatient and ambulatory care settings. It is widely used in both therapeutic and aesthetic procedures due to its operational simplicity and lower cost. MRI-based HIFU offers higher precision through advanced imaging and real-time thermal monitoring, making it ideal for complex tumor ablation cases. Although more expensive, it ensures superior targeting accuracy and safety, supporting its use in advanced clinical applications.

In the high intensity focused ultrasound market, the application segment includes oncology, urology, gynecology, aesthetics, and others. Oncology leads the market, accounting for approximately $428.2 Million in 2025, driven by increasing use of HIFU for non-invasive tumor ablation in liver, prostate, and kidney cancers. Urology applications focus on prostate disease treatment with reduced side effects compared to traditional surgery. Gynecology applications include treatment of uterine fibroids and adenomyosis. The aesthetics segment is expanding rapidly due to growing demand for non-invasive skin tightening and fat reduction procedures.

Geographical Overview

North America remains the largest regional market for high-intensity focused ultrasound (HIFU), accounting for over 35% share in 2025. Market leadership is supported by strong clinical adoption of advanced HIFU systems across leading U.S. hospitals. Widespread use in non-invasive treatments for prostate cancer, neurological disorders, and other therapeutic applications continues to drive regional dominance. The presence of advanced healthcare infrastructure, early regulatory approvals, and increasing preference for minimally invasive procedures further strengthens North America's position as the key hub for HIFU technology adoption and clinical innovation.

The Middle East & Africa region is the fastest-growing market for high-intensity focused ultrasound, expected to register a CAGR of around 9.8% during the forecast period. Growth is supported by expanding healthcare modernization initiatives, rising medical tourism, and increasing adoption of non-invasive treatment technologies. Countries such as Saudi Arabia and the UAE are investing heavily in advanced hospital infrastructure and next-generation oncology and women's health solutions, accelerating the deployment of HIFU systems across private and public healthcare facilities.

Key Trends and Drivers

Emergence of Outpatient HIFU Centers

The high intensity focused ultrasound market is increasingly shifting toward outpatient treatment models, driven by demand for minimally invasive, cost-effective, and faster recovery procedures. Specialized clinics are expanding access beyond traditional hospital settings, improving patient convenience and procedural efficiency. In North America, outpatient providers such as HIFU Prostate Services have performed over 6,000 procedures, highlighting strong adoption in community-based care. This expansion of clinic-based networks is enabling wider access to non-invasive prostate cancer treatments.

Rising Prevalence of Uterine Fibroids

The high intensity focused ultrasound market is being strongly driven by the rising prevalence of uterine fibroids and the increasing demand for non-invasive, uterus-preserving treatment options. According to the U.S. National Institutes of Health (NIH), 20-25% of women of reproductive age are affected by fibroids, with prevalence rising significantly with age. Fibroids also account for a substantial share of gynecology visits and surgical procedures, including hysterectomies, highlighting a large untreated patient pool. This growing disease burden is encouraging adoption of HIFU as a safer alternative to surgery, offering outpatient treatment with reduced complications, faster recovery, and improved patient acceptance globally.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Technology
• 2.3 Key Market Highlights by Device
• 2.4 Key Market Highlights by Application
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by End-User

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTLE Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Ultrasound-based HIFU
  • 4.1.2 MRI-based HIFU
• 4.2 Market Size & Forecast by Technology (2020-2035)
  • 4.2.1 Non-invasive
  • 4.2.2 Minimally Invasive
• 4.3 Market Size & Forecast by Device (2020-2035)
  • 4.3.1 Standalone Devices
  • 4.3.2 Portable Devices
• 4.4 Market Size & Forecast by Application (2020-2035)
  • 4.4.1 Oncology
  • 4.4.2 Urology
  • 4.4.3 Gynecology
  • 4.4.4 Aesthetics
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Transducer
  • 4.5.2 Control System
  • 4.5.3 Imaging System
  • 4.5.4 Others
• 4.6 Market Size & Forecast by End-User (2020-2035)
  • 4.6.1 Hospitals
  • 4.6.2 Imaging Centers
  • 4.6.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Technology
    • 5.2.1.3 Device
    • 5.2.1.4 Application
    • 5.2.1.5 Component
    • 5.2.1.6 End-User
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Technology
    • 5.2.2.3 Device
    • 5.2.2.4 Application
    • 5.2.2.5 Component
    • 5.2.2.6 End-User
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Technology
    • 5.2.3.3 Device
    • 5.2.3.4 Application
    • 5.2.3.5 Component
    • 5.2.3.6 End-User
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Technology
    • 5.3.1.3 Device
    • 5.3.1.4 Application
    • 5.3.1.5 Component
    • 5.3.1.6 End-User
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Technology
    • 5.3.2.3 Device
    • 5.3.2.4 Application
    • 5.3.2.5 Component
    • 5.3.2.6 End-User
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Technology
    • 5.3.3.3 Device
    • 5.3.3.4 Application
    • 5.3.3.5 Component
    • 5.3.3.6 End-User
• 5.4 Europe Market Size (2020-2035)
  • 5.4.1 Germany
    • 5.4.1.1 Type
    • 5.4.1.2 Technology
    • 5.4.1.3 Device
    • 5.4.1.4 Application
    • 5.4.1.5 Component
    • 5.4.1.6 End-User
  • 5.4.2 France
    • 5.4.2.1 Type
    • 5.4.2.2 Technology
    • 5.4.2.3 Device
    • 5.4.2.4 Application
    • 5.4.2.5 Component
    • 5.4.2.6 End-User
  • 5.4.3 United Kingdom
    • 5.4.3.1 Type
    • 5.4.3.2 Technology
    • 5.4.3.3 Device
    • 5.4.3.4 Application
    • 5.4.3.5 Component
    • 5.4.3.6 End-User
  • 5.4.4 Spain
    • 5.4.4.1 Type
    • 5.4.4.2 Technology
    • 5.4.4.3 Device
    • 5.4.4.4 Application
    • 5.4.4.5 Component
    • 5.4.4.6 End-User
  • 5.4.5 Italy
    • 5.4.5.1 Type
    • 5.4.5.2 Technology
    • 5.4.5.3 Device
    • 5.4.5.4 Application
    • 5.4.5.5 Component
    • 5.4.5.6 End-User
  • 5.4.6 Rest of Europe
    • 5.4.6.1 Type
    • 5.4.6.2 Technology
    • 5.4.6.3 Device
    • 5.4.6.4 Application
    • 5.4.6.5 Component
    • 5.4.6.6 End-User
• 5.5 Asia-Pacific Market Size (2020-2035)
  • 5.5.1 China
    • 5.5.1.1 Type
    • 5.5.1.2 Technology
    • 5.5.1.3 Device
    • 5.5.1.4 Application
    • 5.5.1.5 Component
    • 5.5.1.6 End-User
  • 5.5.2 India
    • 5.5.2.1 Type
    • 5.5.2.2 Technology
    • 5.5.2.3 Device
    • 5.5.2.4 Application
    • 5.5.2.5 Component
    • 5.5.2.6 End-User
  • 5.5.3 South Korea
    • 5.5.3.1 Type
    • 5.5.3.2 Technology
    • 5.5.3.3 Device
    • 5.5.3.4 Application
    • 5.5.3.5 Component
    • 5.5.3.6 End-User
  • 5.5.4 Japan
    • 5.5.4.1 Type
    • 5.5.4.2 Technology
    • 5.5.4.3 Device
    • 5.5.4.4 Application
    • 5.5.4.5 Component
    • 5.5.4.6 End-User
  • 5.5.5 Australia
    • 5.5.5.1 Type
    • 5.5.5.2 Technology
    • 5.5.5.3 Device
    • 5.5.5.4 Application
    • 5.5.5.5 Component
    • 5.5.5.6 End-User
  • 5.5.6 Taiwan
    • 5.5.6.1 Type
    • 5.5.6.2 Technology
    • 5.5.6.3 Device
    • 5.5.6.4 Application
    • 5.5.6.5 Component
    • 5.5.6.6 End-User
  • 5.5.7 Rest of APAC
    • 5.5.7.1 Type
    • 5.5.7.2 Technology
    • 5.5.7.3 Device
    • 5.5.7.4 Application
    • 5.5.7.5 Component
    • 5.5.7.6 End-User
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Technology
    • 5.6.1.3 Device
    • 5.6.1.4 Application
    • 5.6.1.5 Component
    • 5.6.1.6 End-User
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Technology
    • 5.6.2.3 Device
    • 5.6.2.4 Application
    • 5.6.2.5 Component
    • 5.6.2.6 End-User
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Technology
    • 5.6.3.3 Device
    • 5.6.3.4 Application
    • 5.6.3.5 Component
    • 5.6.3.6 End-User
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Technology
    • 5.6.4.3 Device
    • 5.6.4.4 Application
    • 5.6.4.5 Component
    • 5.6.4.6 End-User
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Technology
    • 5.6.5.3 Device
    • 5.6.5.4 Application
    • 5.6.5.5 Component
    • 5.6.5.6 End-User

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Insightec Ltd.
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 EDAP TMS S.A.
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Chongqing Haifu Medical Technology Co., Ltd.
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Philips Healthcare
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Sonablate (SonaCare Medical)
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Theraclion SA
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 ALPINION Medical Systems
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Profound Medical Corp.
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Ultherapy (Merz Aesthetics)
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 HIFU Prostate Services
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Vermon S.A.
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 FUSMobile Inc.
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 ULTRAISER
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Lynton Lasers Ltd.
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us